Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer

Gynecologic Oncology

Volumn 118, Issue 3, 2010, Pages 237-243

  Staff, Anne Cathrine ^a,b   Bock, Annika J ^a,c   Becker, Caroline ^a   Kempf, Tibor ^d   Wollert, Kai C ^d   Davidson, Ben ^b,c  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Biomarker; GDF 15; Gynecological cancer; Ovarian cancer; Survival

Indexed keywords

BIOLOGICAL MARKER; GROWTH DIFFERENTIATION FACTOR 15; TUMOR MARKER;

ADULT; ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; CYSTADENOMA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNORADIOMETRIC ASSAY; MIDDLE AGED; OVARIAN DISEASES; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77955555369     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.05.032     Document Type: Article

References (35)

1. D.L. Clarke-Pearson Clinical practice. Screening for ovarian cancer N Engl J Med 361 9-7-2009 170 177
2. M.R. Bootcov, A.R. Bauskin, S.M. Valenzuela, A.G. Moore, M. Bansal, and X.Y. He MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily Proc Natl Acad Sci U S A 94 14-10-1997 11514 11519
3. D.A. Brown, C. Stephan, R.L. Ward, M. Law, M. Hunter, and A.R. Bauskin Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis Clin Cancer Res 12 1-1-2006 89 96
4. L.N. Lawton, M.F. Bonaldo, P.C. Jelenc, L. Qiu, S.A. Baumes, and R.A. Marcelino Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta Gene 203 5-12-1997 17 26
5. A.G. Moore, D.A. Brown, W.D. Fairlie, A.R. Bauskin, P.K. Brown, and M.L. Munier The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women J Clin Endocrinol Metab 85 2000 4781 4788
6. M. Sugulle, R. Dechend, F. Herse, M.S. Weedon-Fekjaer, G.M. Johnsen, and K.B. Brosnihan Circulating and placental growth-differentiation factor 15 in preeclampsia and in pregnancy complicated by diabetes mellitus Hypertension 54 2009 106 112
7. S. Tong, B. Marjono, D.A. Brown, S. Mulvey, S.N. Breit, and U. Manuelpillai Serum concentrations of macrophage inhibitory cytokine 1 (MIC 1) as a predictor of miscarriage Lancet 363 10-1-2004 129 130
8. D.A. Brown, S.N. Breit, J. Buring, W.D. Fairlie, A.R. Bauskin, and T. Liu Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study Lancet 359 22-6-2002 2159 2163
9. J.B. Welsh, L.M. Sapinoso, S.G. Kern, D.A. Brown, T. Liu, and A.R. Bauskin Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum Proc Natl Acad Sci U S A 100 18-3-2003 3410 3415
10. W.D. Fairlie, A.G. Moore, A.R. Bauskin, P.K. Russell, H.P. Zhang, and S.N. Breit MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation J Leukoc Biol 65 1999 2 5
11. T. Liu, A.R. Bauskin, J. Zaunders, D.A. Brown, S. Pankhurst, and P.J. Russell Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells Cancer Res 63 15-8-2003 5034 5040
12. T.A. Zimmers, X. Jin, E.C. Hsiao, S.A. McGrath, A.F. Esquela, and L.G. Koniaris Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury Shock 23 2005 543 548
13. V.M. Paralkar, A.L. Vail, W.A. Grasser, T.A. Brown, H. Xu, and S. Vukicevic Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family J Biol Chem 273 29-5-1998 13760 13767
14. J. Koopmann, P. Buckhaults, D.A. Brown, M.L. Zahurak, N. Sato, and N. Fukushima Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers Clin Cancer Res 10 1-4-2004 2386 2392
15. T. Nakamura, A. Scorilas, C. Stephan, G.M. Yousef, G. Kristiansen, and K. Jung Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues Br J Cancer 88 7-4-2003 1101 1104
16. N.J. de Wit, J. Rijntjes, J.H. Diepstra, T.H. Van Kuppevelt, U.H. Weidle, and D.J. Ruiter Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays Br J Cancer 92 20-6-2005 2249 2261
17. D.A. Brown, R.L. Ward, P. Buckhaults, T. Liu, K.E. Romans, and N.J. Hawkins MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma Clin Cancer Res 9 2003 2642 2650
18. F. Weber, L. Shen, M.A. Aldred, C.D. Morrison, A. Frilling, and M. Saji Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination J Clin Endocrinol Metab 90 2005 2512 2521
19. E. Odegaard, B. Davidson, B.V. Elgaaen, M.K. Fagerhol, V. Engh, and M. Onsrud Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary Am J Obstet Gynecol 198 2008 418.e1 418.e7
20. E. Odegaard, B. Davidson, V. Engh, M. Onsrud, and A.C. Staff Assessment of endoglin and calprotectin as potential biomarkers in ovarian carcinoma and borderline tumors of the ovary Am J Obstet Gynecol 199 2008 533.e1 533.e8
21. T. Kempf, R. Horn-Wichmann, G. Brabant, T. Peter, T. Allhoff, and G. Klein Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay Clin Chem 53 2007 284 291
22. I. Jacobs, D. Oram, J. Fairbanks, J. Turner, C. Frost, and J.G. Grudzinskas A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer Br J Obstet Gynaecol 97 1990 922 929
23. S. Tingulstad, B. Hagen, F.E. Skjeldestad, M. Onsrud, T. Kiserud, and T. Halvorsen Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses Br J Obstet Gynaecol 103 1996 826 831
24. K.C. Wollert, T. Kempf, T. Peter, S. Olofsson, S. James, and N. Johnston Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome Circulation 115 27-2-2007 962 971
25. T. Kempf, H.S. von, T. Peter, T. Allhoff, M. Cicoira, and W. Doehner Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure J Am Coll Cardiol 50 11-9-2007 1054 1060
26. T. Kempf, J.M. Sinning, A. Quint, C. Bickel, C. Sinning, and P.S. Wild Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study Circ Cardiovasc Genet 2 2009 286 292
27. J.S. Kim, S.J. Baek, T. Sali, and T.E. Eling The conventional nonsteroidal anti-inflammatory drug sulindac sulfide arrests ovarian cancer cell growth via the expression of NAG-1/MIC-1/GDF-15 Mol Cancer Ther 4 2005 487 493
28. A.J. Schetter, N.H. Heegaard, and C.C. Harris Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways Carcinogenesis 31 2010 37 49
29. W. Shan, and J. Liu Inflammation: a hidden path to breaking the spell of ovarian cancer Cell Cycle 8 1-10-2009 3107 3111
30. M.K. Agarwal, K. Hastak, M.W. Jackson, S.N. Breit, G.R. Stark, and M.L. Agarwal Macrophage inhibitory cytokine 1 mediates a p53-dependent protective arrest in S phase in response to starvation for DNA precursors Proc Natl Acad Sci U S A 103 31-10-2006 16278 16283
31. M. Tan, Y. Wang, K. Guan, and Y. Sun PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway Proc Natl Acad Sci U S A 97 4-1-2000 109 114
32. P.X. Li, J. Wong, A. Ayed, D. Ngo, A.M. Brade, and C. Arrowsmith Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression J Biol Chem 275 30-6-2000 20127 20135
33. A.R. Bauskin, D.A. Brown, T. Kuffner, H. Johnen, X.W. Luo, and M. Hunter Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer Cancer Res 66 15-5-2006 4983 4986
34. M. Albertoni, P.H. Shaw, M. Nozaki, S. Godard, M. Tenan, and M.F. Hamou Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1 Oncogene 21 20-6-2002 4212 4219
35. A.R. Bauskin, D.A. Brown, S. Junankar, K.K. Rasiah, S. Eggleton, and M. Hunter The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome Cancer Res 65 15-3-2005 2330 2336